Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


UPDATE: AbbVie And I-Mab To Collaborate On Development And Commercialization Of I-Mab's Anti-CD47 Monoclonal Antibody Lemzoparlimab


Benzinga | Sep 4, 2020 07:04AM EDT

UPDATE: AbbVie And I-Mab To Collaborate On Development And Commercialization Of I-Mab's Anti-CD47 Monoclonal Antibody Lemzoparlimab






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC